BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 15, 2011
 |  BC Week In Review  |  Company News  |  Other News

Pozen, Dr. Reddy's, Mylan, Par Pharmaceutical neurology news

A judge in the U.S. District Court for the Eastern District of Texas ruled that Pozen's U.S. Patent Nos. 6,060,499; 6,586,458; and 7,332,183 covering migraine drug Treximet sumatriptan/naproxen are valid and enforceable. The court ruling precluded...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >